🚀Meet the 2026 ATMP Catalyst cohort:
ATF6-Based Immunotherapy (idibell.bsky.social), OneChain Immunotherapeutics, AdCerebri (ibecbarcelona.eu), Mutation-Specific CAR-T for FGFR2-Driven Endometrial Cancer (vhio.bsky.social), CAR-STAb-T Cell Therapy (Banc de sang i teixits) and VIOLET Pharmaceuticals